Senior insider sale
Chief Financial Officer at DYNE THERAPEUTICS, INC. — senior position signals high conviction
$95.3K
4.16K shares
What this filing means
LUCERA ERICK plans to sell 4.16K shares of DYNE THERAPEUTICS, INC. valued at approximately $95.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001972481-26-000259
Officer· Chief Financial Officer
Since Feb 2026
4.16K
Shares to sell
$95.3K
Approx. market value
4.06K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
8/12/2026
4.06KTotal acquired4.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2026 | Restricted Stock Units Equity Compensation | 4.06K | — |
| Total | 4.06K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.36K
Market value
$48.1K
6/25/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.80K
Market value
$47.2K
8/13/2026
Total
Units
4.16K
Value
$95.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 2.36K | $48.1K | — | Completed |
| Planned — Approximate Date | ||||
8/13/2026 | 1.80K | $47.2K | Nasdaq | Planned |
| Total | 4.16K | $95.3K | ||